CLINICAL SIGNIFICANT P-GLYCOPROTEIN DRUG INTERACTIONS?

被引：0
|
作者：
Lee, Caroline A. [1 ]
Fenner, Katherine S. [2 ]
Kempshall, Sarah [2 ]
Cook, Jack [3 ]
Ware, Joseph Alan [4 ]
Troutman, Matthew D. [5 ]
机构：
[1] Pfizer Inc, La Jolla Labs, Dept PDM, San Diego, CA 92121 USA
[2] Pfizer Global Res & Dev, Pharmacokinet Dynam & Metab, Sandwich, Kent, England
[3] Pfizer, Clin Pharmacol, New London, CT 06320 USA
[4] Pfizer Global Rsch & Develop, Dept PKDM, Ann Arbor, MI 48105 USA
[5] Pfizer Inc, Dept PDM, Groton, CT 06340 USA
来源：
DRUG METABOLISM REVIEWS | 2008年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
316
引用
收藏
页码：208 / 208
页数：1
相关论文
共 50 条
  • [1] Clinical Implications of P-Glycoprotein Modulation in Drug–Drug Interactions
    Marie Lund
    Tonny Studsgaard Petersen
    Kim Peder Dalhoff
    Drugs, 2017, 77 : 859 - 883
  • [2] Clinical Implications of P-Glycoprotein Modulation in Drug-Drug Interactions
    Lund, Marie
    Petersen, Tonny Studsgaard
    Dalhoff, Kim Peder
    DRUGS, 2017, 77 (08) : 859 - 883
  • [3] P-glycoprotein, a source of drug interactions
    Roussin, Fanny
    Picard, Nicolas
    ACTUALITES PHARMACEUTIQUES, 2020, 59 (601): : 48 - 52
  • [4] Evaluation of drug interactions with P-glycoprotein in drug discovery:: In vitro assessment of the potential for drug-drug interactions with P-glycoprotein
    Hochman, JH
    Yamazaki, M
    Ohe, T
    Lin, JH
    CURRENT DRUG METABOLISM, 2002, 3 (03) : 257 - 273
  • [5] Psychotropic Drug–Drug Interactions Involving P-Glycoprotein
    Yumiko Akamine
    Norio Yasui-Furukori
    Ichiro Ieiri
    Tsukasa Uno
    CNS Drugs, 2012, 26 : 959 - 973
  • [6] Computer Evaluation of Drug Interactions with P-Glycoprotein
    Lagunin, A. A.
    Gloriozova, T. A.
    Dmitriev, A. V.
    Volgina, N. E.
    Poroikov, V. V.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2013, 154 (04) : 521 - 524
  • [7] Computer Evaluation of Drug Interactions with P-Glycoprotein
    A. A. Lagunin
    T. A. Gloriozova
    A. V. Dmitriev
    N. E. Volgina
    V. V. Poroikov
    Bulletin of Experimental Biology and Medicine, 2013, 154 : 521 - 524
  • [8] Role of P-glycoprotein in statin drug interactions
    Holtzman, Carol W.
    Wiggins, Barbara S.
    Spinler, Sarah A.
    PHARMACOTHERAPY, 2006, 26 (11): : 1601 - 1607
  • [9] The contribution of P-glycoprotein to pharmacokinetic drug-drug interactions
    Yu, DK
    JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (12): : 1203 - 1211
  • [10] P-glycoprotein related drug interactions: clinical importance and a consideration of disease states
    Lee, Caroline A.
    Cook, Jack A.
    Reyner, Eric L.
    Smith, Dennis A.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2010, 6 (05) : 603 - 619
12345